FDA Inspection 1178651 - Opto-Pharm Pte Ltd. - September 01, 2022

Record Details

This FDA Inspection record concerns Opto-Pharm Pte Ltd., with an inspection on September 1, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: Opto-Pharm Pte Ltd.
Inspection Date: September 1, 2022
Product Type: Drugs
Office: Center for Drug Evaluation and Research

Open in Dashboard

ID · 3f4fae1e-2dde-411d-aeb6-4195a22ee1c3

Violation Codes10

21 CFR 211.113(b)21 CFR 211.160(a)21 CFR 211.18221 CFR 211.19221 CFR 211.198(a)21 CFR 211.22(c)21 CFR 211.22(d)21 CFR 211.25(a)21 CFR 211.42(c)(10)(iv)21 CFR 211.42(c)(10)(v)

Full citation text and observation details available on the Dashboard.